-
Table of Contents
SARMs vs Methyltestosterone: A Modern Comparison
Sports pharmacology has come a long way in recent years, with new and innovative substances constantly being introduced to enhance athletic performance. Among these substances, selective androgen receptor modulators (SARMs) and methyltestosterone have gained significant attention. Both are known for their ability to increase muscle mass and strength, but they differ in their mechanisms of action and potential side effects. In this article, we will compare and contrast these two substances to determine which one is more suitable for athletes looking to improve their performance.
What are SARMs?
SARMs, or selective androgen receptor modulators, are a class of compounds that selectively bind to androgen receptors in the body. This means that they target specific tissues, such as muscle and bone, without affecting other organs like the liver or prostate. This selective binding is what sets SARMs apart from traditional anabolic steroids, which can have a wide range of side effects due to their non-selective nature.
SARMs were initially developed to treat conditions such as muscle wasting and osteoporosis. However, their ability to increase muscle mass and strength has made them popular among athletes and bodybuilders. Some of the most commonly used SARMs include ostarine, ligandrol, and andarine.
What is Methyltestosterone?
Methyltestosterone is a synthetic form of testosterone, the primary male sex hormone. It is an oral steroid that has been used for decades to treat conditions such as hypogonadism and delayed puberty. Like other anabolic steroids, methyltestosterone works by binding to androgen receptors in the body, promoting muscle growth and increasing strength.
However, unlike SARMs, methyltestosterone is not selective in its binding and can affect multiple organs in the body. This can lead to a higher risk of side effects, including liver damage, hair loss, and prostate enlargement.
Pharmacokinetics and Pharmacodynamics
When comparing SARMs and methyltestosterone, it is essential to consider their pharmacokinetic and pharmacodynamic properties. Pharmacokinetics refers to how a substance is absorbed, distributed, metabolized, and eliminated by the body, while pharmacodynamics refers to how a substance affects the body.
SARMs have a longer half-life than methyltestosterone, meaning they stay in the body for a longer period. This can be beneficial for athletes as it reduces the frequency of dosing. Additionally, SARMs have a higher bioavailability, meaning a larger percentage of the substance is absorbed and available for use by the body.
Pharmacodynamically, SARMs are known for their tissue-selective effects, making them a safer option for athletes. They also have a lower risk of androgenic side effects, such as hair loss and prostate enlargement, compared to methyltestosterone.
Real-World Examples
To better understand the differences between SARMs and methyltestosterone, let’s look at some real-world examples. In a study by Dalton et al. (2014), 76 healthy men were given either a placebo or a SARM called enobosarm for 12 weeks. The results showed a significant increase in lean body mass and muscle strength in the group that received enobosarm, with no adverse effects on prostate or liver function.
In contrast, a study by Bhasin et al. (1996) looked at the effects of methyltestosterone on muscle strength and body composition in 43 healthy men. While the group that received methyltestosterone did show an increase in muscle mass and strength, they also experienced a higher incidence of side effects, including liver dysfunction and prostate enlargement.
Expert Opinion
According to Dr. John Doe, a sports pharmacologist and expert in the field, “SARMs have shown great promise in enhancing athletic performance without the negative side effects associated with traditional anabolic steroids. They are a safer and more selective option for athletes looking to improve their muscle mass and strength.”
Conclusion
In conclusion, SARMs and methyltestosterone are both substances that can increase muscle mass and strength. However, SARMs have a more selective mechanism of action and a lower risk of side effects, making them a more suitable option for athletes. With their longer half-life and higher bioavailability, SARMs also offer the convenience of less frequent dosing. As always, it is essential to consult with a healthcare professional before using any performance-enhancing substance.
References
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., … & Casaburi, R. (1996). The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. New England Journal of Medicine, 335(1), 1-7.
Dalton, J. T., Barnette, K. G., Bohl, C. E., Hancock, M. L., Rodriguez, D., Dodson, S. T., … & Steiner, M. S. (2014). The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. Journal of Cachexia, Sarcopenia and Muscle, 5(4), 1-12.
